H
Loading...
Loading...
Wharton’s jelly allografts are umbilical-cord matrix products used as 361 HCT/Ps when minimally manipulated and homologous. High hyaluronic-acid content is a composition fact, not a stem-cell claim.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18.
Wharton's jelly allografts rich in hyaluronic acid and ECM components. HCT/P 361 compliant from FDA-registered sources.
Wharton’s jelly allografts stay in the 361 lane only when labeling and use stay homologous. If a flyer says pluripotent cure, it does not belong next to our IFU. We will walk indication language with your staff.
Wharton’s jelly is gelatinous cord matrix rich in HA and collagen. Describe composition accurately. Do not imply hematopoietic stem-cell transplantation.
Different presentations exist for different sites. Match IFU to anatomy.
State boards and the FTC have warned clinics over regenerative ads. Website copy should match the 361 label.
No. It is a structural tissue allograft in the 361 lane.
FDA-registered tissue banks with donor screening.
No. Homologous use and IFU govern site and indication.
Handling, thaw, and documentation — not a new medical specialty certificate from a distributor.
Contact us today to learn how Hawk Medical can support your practice.
We're not just a distributor - we're healthcare providers who understand your challenges
We own and operate medical clinics, so we understand your real-world challenges
All products meet strict regulatory requirements including HCT/P 361 compliance
Personal account management and ongoing training for your entire team
10+ years of experience helping practices implement successful programs
Learn more about related treatments, solutions, and resources
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.